Thomas Suchy, MD
Interventional Pain Medicine · Buffalo, NYNPI 1477999456
Payments from drug & device makers
Across 602 payments — averaging $47.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$18K
- Nevro Corp.$3K
- Relievant Medsystems, Inc.$1K
- Boston Scientific$1K
- Vertos Medical, Inc.$1K
- Globus Medical$650
- plus $3K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 329 | $18,255 |
| Nevro Corp. | 75 | $3,342 |
| Relievant Medsystems, Inc. | 14 | $1,415 |
| Boston Scientific | 41 | $1,366 |
| Vertos Medical, Inc. | 17 | $1,265 |
| Globus Medical | 17 | $650 |
| Saluda Medical Americas, Inc. | 12 | $444 |
| Medtronic(2 entities) | 13 | $415 |
| Si-bone, Inc. | 8 | $349 |
| SPR Therapeutics, Inc | 13 | $184 |
| Trisalus Life Sciences, Inc. | 17 | $173 |
| MDD US Operations, LLC | 6 | $112 |
| Tersera Therapeutics LLC | 4 | $90 |
| Axogen | 1 | $90 |
| Foundation Fusion Solutions, LLC | 4 | $73 |
| Avanos Medical | 2 | $73 |
| Curonix LLC | 2 | $72 |
| USWM, LLC | 3 | $62 |
| Ipsen Biopharmaceuticals, Inc | 4 | $62 |
| Collegium Pharmaceutical, Inc. | 3 | $50 |
| Biohaven Pharmaceuticals, Inc. | 3 | $46 |
| Biodelivery Sciences International, Inc. | 4 | $45 |
| Pfizer | 2 | $41 |
| Stimwave Technologies Incorporated | 2 | $37 |
| Stryker | 1 | $30 |
| Almatica Pharma LLC | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $19 |
| Eisai Inc. | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
How this compares
$28,837 in reported general payments places this provider in the 85th percentile of 132 interventional pain medicine providers in New York.
See all interventional pain medicine providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in Buffalo
- Sathish ModuguHartsdale$1.3M
- Neel MehtaNew York$655K
- Corey HunterNew York$571K
- Hemant KaliaRochester$234K
- Martin FerrilloAlbany$164K
- George ChaseKew Gardens$102K
- Kimberly SackheimNew York$102K
- Jafar SiddiquiWilliamsville$70K
- Suelane OuroNew York$68K
- Gerard DegregorisNew York$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.